More tools:Markets·Screener·Research·Chat

Prime Medicine, Inc. Common Stock (PRME) Financial Statements

Prime Medicine, Inc. Common Stock
SIC 2836 · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
FIGI BBG011RT3R64
XNAS · usd
3.56▼ 0.14 (-3.78%)
As of 2026-09-08
Valuation
Market Cap
Enterprise Value
Trailing P/E—
Price / Sales
EV / Revenue
EV / EBITDA
Financial Highlights
Revenue (TTM)
Net Income (TTM)
EBITDA
Diluted EPS (TTM)
EBITDA Margin
Net Debt
Trading Information
Previous Close3.70
Day's Range3.41 – 3.65
52-Week Range2.67 – 6.94
Volume3.6M
Avg Volume2.6M
Share Statistics
Shares Outstanding
Employees146
ExchangeXNAS
Listed2022-10-20
Share count as of July 31, 2026
Loading Income Statement…
Key questions about Prime Medicine, Inc. Common Stock (PRME)
What is Prime Medicine, Inc. Common Stock's Market Cap?
Prime Medicine, Inc. Common Stock's Market Cap is $645.7M, based on as-reported figures from SEC (XBRL) filings.
What is Prime Medicine, Inc. Common Stock's Enterprise Value?
Prime Medicine, Inc. Common Stock's Enterprise Value is $598.3M, based on as-reported figures from SEC (XBRL) filings.
What is Prime Medicine, Inc. Common Stock's Price / Sales?
Prime Medicine, Inc. Common Stock's Price / Sales is 139.4×, based on as-reported figures from SEC (XBRL) filings.
What is Prime Medicine, Inc. Common Stock's EV / Revenue?
Prime Medicine, Inc. Common Stock's EV / Revenue is 129.2×, based on as-reported figures from SEC (XBRL) filings.
What is Prime Medicine, Inc. Common Stock's EV / EBITDA?
Prime Medicine, Inc. Common Stock's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.
What is Prime Medicine, Inc. Common Stock's Revenue (TTM)?
Prime Medicine, Inc. Common Stock's Revenue (TTM) is $4.6M, based on as-reported figures from SEC (XBRL) filings.
What is Prime Medicine, Inc. Common Stock's Net Income (TTM)?
Prime Medicine, Inc. Common Stock's Net Income (TTM) is -$187.9M, based on as-reported figures from SEC (XBRL) filings.
What is Prime Medicine, Inc. Common Stock's EBITDA?
Prime Medicine, Inc. Common Stock's EBITDA is -$189.1M, based on as-reported figures from SEC (XBRL) filings.
What is Prime Medicine, Inc. Common Stock's Diluted EPS (TTM)?
Prime Medicine, Inc. Common Stock's Diluted EPS (TTM) is -1.04, based on as-reported figures from SEC (XBRL) filings.
What is Prime Medicine, Inc. Common Stock's EBITDA Margin?
Prime Medicine, Inc. Common Stock's EBITDA Margin is -4082.9%, based on as-reported figures from SEC (XBRL) filings.
Showing the most recent year. Subscribe for full statement history.
Income Statement(in thousands of USD, except per-share data)
Source: Akyla.ai
Line ItemJun 30, 2026Mar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022
Revenue:
Collaboration revenue — related party
YoY growth+3.5%-41.1%-61.6%+486.1%
Operating expenses:
Research and development
General and administrative
Total operating expenses
% of revenue3850.9%6017.5%5900.5%4506.0%
Loss from operations
% of revenue-3750.9%-5917.5%-5800.5%-4406.0%
Other income:
Interest income
Accretion (amortization) of investments
Change in fair value of short-term investment — related party
Other income, net
Total other income, net
Net loss attributable to common stockholders, basic
Net loss attributable to common stockholders, diluted
Net loss per share attributable to common stockholders, basic (in dollars per share)
Net loss per share attributable to common stockholders, diluted (in dollars per share)